钛媒体App 12月9日消息，有网友发现，继诺和盈之后，诺和诺德另一款明星产品口服版司美在美团首发开售。据悉，另一款减重明星产品礼来替尔泊肽也已在美团开启到店预订服务，近期或将首发上线。减重赛道持续火热，今年第四季度，大量GLP-1药物集中在国内上市，行业人士指出，同日预售也是“减重一哥”司美格鲁肽和“减重新秀”替尔泊肽在销售端的首次正面对决。
减重赛道又传新消息，两大明星药本周将在美团首发
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha